Major Rating Factors:
Poor long-term capitalization index (1.3 on a scale of 0 to 10) based on weak current risk adjusted capital (severe and moderate loss scenarios). Weak profitability index (1.8) with operating losses during 2022, 2024 and 2025. Weak overall results on stability tests (2.1) including excessive premium growth, weak risk diversification and negative cash flow from operations for 2025. The largest net exposure for one risk is excessive at 7.9% of capital.
Other Rating Factors:
Fair reserve development (4.0) as reserves have generally been sufficient to cover claims. In 2025 the one year reserve development was 155.9% deficient. Excellent liquidity (8.1) with ample operational cash flow and liquid investments.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
F - Negative cash flow.
G - Fast asset or premium growth.
Principal Lines of Business:
Med mal (99.4%), other (0.6%)
Licensed in:
DC
Principal Investments:
Investment grade bonds (74.9%), common stock (12.8%), cash (12.3%)
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
6 Wellness Way
Latham, NY 12110
Latham, NY 12110
Phone Number
(802) 264-9555
NAIC Number
15798
Website
--
Largest Affiliates
There are no affiliate to display.